Brian Biesman, MD
Ophthalmology · Nashville, TNNPI 1700848934
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (45.2%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by AbbVie at 47.1% of the total. Among ophthalmology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 278 payments — averaging $2264.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$296K
- Solta Medical, A Division Of Bausch Health US, LLC$191K
- Merz North America, Inc.$77K
- Galderma Laboratories, L.p.$29K
- Lumenis BE LTD$15K
- Endo Pharmaceuticals Inc.$10K
- plus $12K from 7 others
Across 225 payments — averaging $14,137 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$2.1M
- Merz North America, Inc.$771K
- Bausch Health US, LLC$209K
- Endo Pharmaceuticals Inc.$66K
- Galderma Laboratories, L.p.$32K
What the payments were for
- Consulting fees$261,58542%
- Speaking & faculty fees$38,1306%
- Grants$284,45345%
- Travel & lodging$12,7882%
- Food & beverage$8,3021%
- Education$4570%
- Gifts$23,9004%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 117 | $296,309 |
| Solta Medical, A Division Of Bausch Health US, LLC | 23 | $190,748 |
| Merz North America, Inc. | 57 | $77,442 |
| Galderma Laboratories, L.p. | 45 | $28,624 |
| Lumenis BE LTD | 1 | $15,000 |
| Endo Pharmaceuticals Inc. | 13 | $9,870 |
| Revance Therapeutics, Inc. | 16 | $6,782 |
| Pfizer | 1 | $3,750 |
| Botanix SB Inc | 1 | $1,000 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $22 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
| Dermira, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$629,614 in reported general payments places this provider in the 95th percentile of 323 ophthalmology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 19 | $155 |
| Methylprednisolone | 12 | $72 |
| Tramadol Hcl | 43 | $43 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Nashville
- Deborah ShermanNashville$3M
- Edward ChaumNashville$158K
- Jeffrey HornNashville$106K
- Avni FinnNashville$57K
- Louise MawnNashville$56K
- Jeffrey KammerNashville$30K
- Gary JerkinsNashville$15K
- Allison SmithNashville$13K
- Christine ShiehNashville$10K
- Ira ShivitzNashville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.